Researchers from the University of Michigan relied on supercomputers at UC San Diego and elsewhere to help them develop detailed models to better understand how TB spreads throughout the lungs.
UC San Diego School of Medicine research sets the stage for clinicians to potentially one day use levels of a pancreatic cancer patient’s PHLPP1 and PKC enzymes as a prognostic, and for researchers to develop new therapeutic drugs that inhibit PHLPP1 and boost PKC as a means to treat the disease.
A new paper by UC San Diego researchers hypothesizes a possible link between cancer-causing viruses.
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
Every year, at precisely 9 a.m., medical school graduates nationwide find out where they will spend their residencies. On Friday, the 117 members of the 2019 UC San Diego School of Medicine graduating class will be among them.
U.S. News & World Report today released its 2020 guidebook that ranks the nation’s top graduate programs and professional schools, giving high marks to UC San Diego’s innovative programs.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
